List of Studies

Back
Study IDStudy TitleLanguage Clinical Study Result Plain Language Summary
178-CL-008A randomized, double-blind, parallel group, proof of concept study of YM178 in comparison with placebo and tolterodine in patients with symptomatic overactive bladder English


English


178-CL-044A randomized, double-blind, parallel-group, placebo and active controlled, multi-center dose ranging study with the beta-3 agonist YM178 in patients with symptomatic overactive bladder (DRAGON) English


English


178-CL-045YM178 Phase II study - A Randomized, Double-blind, Parallel-group, Placebo-controlled Study in Patients With Symptomatic Overactive Bladder -(Original language of CSR synopsis is Japanese.) Japanese


Japanese


178-CL-046A Randomized, Double-Blind, Parallel Group, Placebo and Active Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects with Symptoms of Overactive Bladder English


English


NextLast

QUICK SEARCH

USEFUL LINKS